Showing results filtered by:
2 Results
Topical Steroid Withdrawal Diagnostic Criteria Defined by NIH Researchers
March 14, 2025
Topical steroid withdrawal (TSW) results in dermatitis that is distinct from eczema and is caused by an excess of NAD+, an essential chemical compound in the body, according to a new study from NIAID researchers.
NIAID Discovery Leads to Novel Probiotic for Eczema
June 26, 2024
NIAID research has led to the availability of a new over-the-counter topical eczema probiotic. The probiotic is based on the discovery by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, that bacteria present on healthy skin called Roseomonas mucosa can safely relieve eczema symptoms in adults and children.
